{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T10:55:23Z","timestamp":1788432923649,"version":"build-2803163510"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T00:00:00Z","timestamp":1734566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T00:00:00Z","timestamp":1734566400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Cardiovasc Drugs"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1007\/s40256-024-00708-7","type":"journal-article","created":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T14:07:38Z","timestamp":1734617258000},"page":"389-398","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Morphine and P2Y12 Inhibitors in ST-Elevation Myocardial Infarction: An Updated Meta-Analysis"],"prefix":"10.1007","volume":"25","author":[{"given":"Ryan","family":"Berry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaled M.","family":"Harmouch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaa","family":"Roto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nomesh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zohaib","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Resha","family":"Khanal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Hamza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasemin","family":"Bahar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasar","family":"Sattar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wael","family":"Aljaroudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timir K.","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7874-4566","authenticated-orcid":false,"given":"M. Chadi","family":"Alraies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,19]]},"reference":[{"issue":"17","key":"708_CR1","first-page":"e418","volume":"116","author":"LA Fleisher","year":"2007","unstructured":"Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikof E, Fleischmann KE, et al. ACC\/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery): developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. Circulation. 2007;116(17):e418\u201399.","journal-title":"Circulation"},{"issue":"6","key":"708_CR2","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.ahj.2005.02.010","volume":"149","author":"TJ Meine","year":"2005","unstructured":"Meine TJ, Roe MT, Chen AY, Patel MR, Washam JB, Ohman EM, et al. Association of intravenous morphine use and outcomes in acute coronary syndromes: results from the CRUSADE quality improvement initiative. Am Heart J. 2005;149(6):1043\u20139.","journal-title":"Am Heart J"},{"issue":"4","key":"708_CR3","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1161\/CIR.0b013e3182742c84","volume":"127","author":"PT O\u2019Gara","year":"2013","unstructured":"O\u2019Gara PT, Kushner FG, Ascheim DD, Casey DE, Chung MK, de Lemos JA, et al. 2013 ACCF\/AHA Guideline for the management of ST-elevation myocardial infarction: executive summary. Circulation. 2013;127(4):529\u201355.","journal-title":"Circulation"},{"issue":"6","key":"708_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2005.08.014","volume":"150","author":"HW Daniell","year":"2005","unstructured":"Daniell HW. Opioid-induced cortisol deficiency may explain much of the increased mortality after the use of morphine during treatment of acute myocardial infarction. Am Heart J. 2005;150(6): e1.","journal-title":"Am Heart J"},{"issue":"1","key":"708_CR5","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3109\/21556660.2014.946604","volume":"3","author":"R Teng","year":"2014","unstructured":"Teng R, Maya J. Absolute bioavailability and regional absorption of ticagrelor in healthy volunteers. J Drug Assess. 2014;3(1):43\u201350.","journal-title":"J Drug Assess."},{"issue":"1\u20133","key":"708_CR6","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.regpep.2009.03.012","volume":"155","author":"P Holzer","year":"2009","unstructured":"Holzer P. Opioid receptors in the gastrointestinal tract. Regul Pept. 2009;155(1\u20133):11\u20137.","journal-title":"Regul Pept"},{"issue":"2","key":"708_CR7","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s40262-014-0230-6","volume":"54","author":"XL Jiang","year":"2015","unstructured":"Jiang XL, Samant S, Lesko LJ, Schmidt S. Clinical pharmacokinetics and pharmacodynamics of clopidogrel. Clin Pharmacokinet. 2015;54(2):147\u201366.","journal-title":"Clin Pharmacokinet"},{"issue":"1","key":"708_CR8","first-page":"5","volume":"5","author":"M Khansari","year":"2013","unstructured":"Khansari M, Sohrabi M, Zamani F. The useage of opioids and their adverse effects in gastrointestinal practice: a review. Middle East J Dig Dis. 2013;5(1):5\u201316.","journal-title":"Middle East J Dig Dis."},{"issue":"4","key":"708_CR9","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1002\/j.2040-4603.2014.tb00587.x","volume":"4","author":"KN Browning","year":"2014","unstructured":"Browning KN, Travagli RA. Central nervous system control of gastrointestinal motility and secretion and modulation of gastrointestinal functions. Compr Physiol. 2014;4(4):1339\u201368.","journal-title":"Compr Physiol"},{"issue":"2","key":"708_CR10","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.ihj.2019.03.003","volume":"71","author":"GN Vaidya","year":"2019","unstructured":"Vaidya GN, Khan A, Ghafghazi S. Effect of morphine use on oral P2Y12 platelet inhibitors in acute myocardial infarction: meta-analysis. Indian Heart J. 2019;71(2):126\u201335.","journal-title":"Indian Heart J"},{"key":"708_CR11","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.ajem.2020.11.003","volume":"41","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Wang N, Gu Q. Effects of morphine on P2Y12 platelet inhibitors in patients with acute myocardial infarction: a meta-analysis. Am J Emerg Med. 2021;41:219\u201328.","journal-title":"Am J Emerg Med"},{"issue":"1","key":"708_CR12","first-page":"76","volume":"96","author":"R Batchelor","year":"2020","unstructured":"Batchelor R, Liu DH, Bloom J, Noaman S, Chan W. Association of periprocedural intravenous morphine use on clinical outcomes in ST-elevation myocardial infarction (STEMI) treated by primary percutaneous coronary intervention: systematic review and meta-analysis. Catheter Cardiovasc Interv. 2020;96(1):76\u201388.","journal-title":"Catheter Cardiovasc Interv"},{"issue":"1","key":"708_CR13","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1002\/cpt.1798","volume":"108","author":"YX Gue","year":"2020","unstructured":"Gue YX, Spinthakis N, Farag M, Kubica J, Siller-Matula JM, Srinivasan M, et al. Impact of preadmission morphine on reinfarction in patients with ST-elevation myocardial infarction treated with percutaneous coronary intervention: a meta-analysis. Clin Pharmacol Ther. 2020;108(1):54\u201362.","journal-title":"Clin Pharmacol Ther"},{"key":"708_CR14","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.ajem.2023.05.010","volume":"70","author":"SW Lee","year":"2023","unstructured":"Lee SW, Kuo N, Hou SK, Kang YN. Effects of morphine and P2Y inhibitor amongst patients with acute coronary syndrome: a meta-analysis of comparative studies. Am J Emerg Med. 2023;70:119\u201326.","journal-title":"Am J Emerg Med"},{"issue":"3","key":"708_CR15","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-025232","volume":"9","author":"GS Duarte","year":"2019","unstructured":"Duarte GS, Nunes-Ferreira A, Rodrigues FB, Pinto FJ, Ferreira JJ, Costa J, et al. Morphine in acute coronary syndrome: systematic review and meta-analysis. BMJ Open. 2019;9(3):e025232.","journal-title":"BMJ Open"},{"issue":"1","key":"708_CR16","doi-asserted-by":"publisher","first-page":"e001593","DOI":"10.1161\/CIRCINTERVENTIONS.114.001593","volume":"8","author":"G Parodi","year":"2015","unstructured":"Parodi G, Bellandi B, Xanthopoulou I, Capranzano P, Capodanno D, Valenti R, et al. Morphine is associated with a delayed activity of oral antiplatelet agents in patients with ST-elevation acute myocardial infarction undergoing primary percutaneous coronary intervention. Circ Cardiovasc Interv. 2015;8(1):e001593.","journal-title":"Circ Cardiovasc Interv"},{"issue":"372","key":"708_CR17","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"29","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;29(372): n71.","journal-title":"BMJ"},{"issue":"358","key":"708_CR18","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j4008","volume":"21","author":"BJ Shea","year":"2017","unstructured":"Shea BJ, Reeves BC, Wells G, Thuku M, Hamel C, Moran J, et al. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ. 2017;21(358): j4008.","journal-title":"BMJ"},{"issue":"11","key":"708_CR19","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JP Higgins","year":"2002","unstructured":"Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539\u201358.","journal-title":"Stat Med"},{"issue":"1","key":"708_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0245433","volume":"16","author":"D Domokos","year":"2021","unstructured":"Domokos D, Szabo A, Banhegyi G, Major L, Kiss RG, Becker D, et al. Impact of periprocedural morphine use on mortality in STEMI patients treated with primary PCI. PLoS\u00a0One. 2021;16(1): e0245433.","journal-title":"PLoS\u00a0One"},{"issue":"366","key":"708_CR21","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898","volume":"28","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;28(366): l4898.","journal-title":"BMJ"},{"issue":"4","key":"708_CR22","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1161\/JAHA.117.006833","volume":"7","author":"M Bonin","year":"2018","unstructured":"Bonin M, Mewton N, Roubille F, Morel O, Cayla G, Angoulvant D, et al. Effect and safety of morphine use in acute anterior ST-segment elevation myocardial infarction. J Am Heart Assoc. 2018;7(4):151.","journal-title":"J Am Heart Assoc"},{"key":"708_CR23","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.116.005426","author":"HB Gwag","year":"2017","unstructured":"Gwag HB, Kim EK, Park TK, Lee JM, Yang JH, Song YB, et al. Cardioprotective effects of intracoronary morphine in ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: a prospective, randomized trial. J Am Heart Assoc. 2017. https:\/\/doi.org\/10.1161\/JAHA.116.005426.","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"708_CR24","doi-asserted-by":"publisher","first-page":"735","DOI":"10.3390\/jcm9030735","volume":"9","author":"I Eitel","year":"2020","unstructured":"Eitel I, Wang J, Stiermaier T, Fuernau G, Feistritzer H-J, Joost A, et al. Impact of morphine treatment on infarct size and reperfusion injury in acute reperfused ST-elevation myocardial infarction. J Clin Med. 2020;9(3):735.","journal-title":"J Clin Med"},{"issue":"2","key":"708_CR25","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s40256-018-0305-0","volume":"19","author":"F Lapostolle","year":"2019","unstructured":"Lapostolle F, Van\u2019t Hof AW, Hamm CW, Stibbe O, Ecollan P, Collet JP, et al. Morphine and ticagrelor interaction in primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: ATLANTIC-morphine. Am J Cardiovasc Drugs. 2019;19(2):173\u201383.","journal-title":"Am J Cardiovasc Drugs"}],"container-title":["American Journal of Cardiovascular Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40256-024-00708-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40256-024-00708-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40256-024-00708-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T02:12:07Z","timestamp":1757124727000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40256-024-00708-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,19]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["708"],"URL":"https:\/\/doi.org\/10.1007\/s40256-024-00708-7","relation":{},"ISSN":["1175-3277","1179-187X"],"issn-type":[{"value":"1175-3277","type":"print"},{"value":"1179-187X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,19]]},"assertion":[{"value":"23 November 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No external funding was used in the preparation of this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"R.B., K.M.H., A.R., N.K., Z.K., R.K., M.H., Y.B., Y.S., W.A., T.K.P., and M.C.A. declare that they have no potential conflicts of interest that might be relevant to the contents of this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All data generated or analyzed during this study are included in this published article (and its supplementary information files).","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability statement"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"R.B. carried out data curation, analysis, investigation, methodology, project administration, writing, reviewing, and editing; K.M.H. carried out data curation, investigation, and writing; A.R. carried out data curation, investigation, and writing; N.K. carried out data curation, investigation, and writing; Z.K. carried out data curation, investigation, and writing; R.K. carried out visualization; M.H. carried out data curation, analysis, investigation, and methodology; Y.B. carried out reviewing, editing, and data validation; Y.S. carried out supervision, reviewing, and editing; W.A. carried out reviewing and editing; T.K.P. carried out reviewing and editing; M.C.A. carried out supervision, reviewing, and editing.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors' contributions"}}]}}